Insider · CIK 0001328736
Adrian Kingshott
director
Files at RXO (RXO, Inc.). First filing Nov 19, 2025, latest Nov 19, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$201k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RXO: RXO, Inc.
RXOOct 9, 2026 · close 29.08
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 61Notable | RXO, Inc. | $101k 9,350 shares | +11% | 0% from low-66% from high | |
| 61Notable | RXO, Inc. | $101k 9,350 shares | +11% | 0% from low-66% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | RXO RXO, Inc. | AGrant or award Restricted Stock Unitderivative | +14,517 | $0.00 | $0 | 148,522 | Jan 6, 2026 |
| Nov 17, 2025 | RXO RXO, Inc. | POpen-market purchase Common Stock | +9,350 | $10.75 | $101k | 91,137 | Nov 19, 2025 |
| Nov 17, 2025 | RXO RXO, Inc. | POpen-market purchase Common Stock | +9,350 | $10.75 | $101k | 91,137 | Nov 19, 2025 |
| Jan 2, 2025 | RXO RXO, Inc. | MOption exercise Restricted Stock Unit | +8,045 | $0.00 | $0 | 81,787 | Jan 6, 2025 |
| Jan 2, 2025 | RXO RXO, Inc. | AGrant or award Restricted Stock Unitderivative | +7,745 | $0.00 | $0 | 7,745 | Jan 6, 2025 |
| Jan 2, 2025 | RXO RXO, Inc. | MOption exercise Restricted Stock Unitderivative | -8,045 | $0.00 | $0 | 0 | Jan 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.